510(k) K852767
K852767 is an FDA 510(k) premarket notification submitted by Panmed, Inc. for the device "ERYTHOCYTE CREATINE". The FDA issued a decision of Substantially Equivalent on November 13, 1986. The device falls under product code JLA (Conversion To Creatinine, Creatine), a Class I device regulated under 21 CFR 862.1210. Panmed, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- November 13, 1986
- Date Received
- June 28, 1985
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Conversion To Creatinine, Creatine
- Device Class
- Class I
- Regulation Number
- 862.1210
- Review Panel
- CH
- Submission Type